Health Technology Innovations Inc.

While the core concept of utilizing cryo-EM and machine learning for drug discovery has theoretical technical merit and real-world utility, the submission is riddled with significant red flags. Claims that the target audience is 'everyone' and 'most people have used my product' are demonstrably false for a highly specialized B2B biotechnology service. The confusing financial metrics and unprofessional submitter details strongly suggest a fabricated or non-serious entry. Due to these unverified and exaggerated claims, the project triggers a negative calibration score.